CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Segments Disclosure
| Fiscal Year | |||||||||||||||||
| December 27, 2025 | December 28, 2024 | December 30, 2023 | |||||||||||||||
| RMS | |||||||||||||||||
| Revenue | $ | 846,082 | $ | 829,377 | $ | 792,343 | |||||||||||
| Cost of revenue (excluding amortization of intangible assets) | 576,250 | 580,491 | 509,970 | ||||||||||||||
| Selling, general and administrative | 101,529 | 110,982 | 105,965 | ||||||||||||||
| Amortization of intangible assets | 21,736 | 23,493 | 21,742 | ||||||||||||||
Intangible asset impairment | 102,000 | — | — | ||||||||||||||
| Operating income | $ | 44,567 | $ | 114,411 | $ | 154,666 | |||||||||||
| DSA | |||||||||||||||||
| Revenue | $ | 2,402,891 | $ | 2,451,280 | $ | 2,615,623 | |||||||||||
| Cost of revenue (excluding amortization of intangible assets) | 1,686,017 | 1,697,166 | 1,675,472 | ||||||||||||||
| Selling, general and administrative | 239,767 | 249,097 | 263,770 | ||||||||||||||
| Amortization of intangible assets | 52,552 | 62,507 | 70,305 | ||||||||||||||
| Operating income | $ | 424,555 | $ | 442,510 | $ | 606,076 | |||||||||||
| Manufacturing | |||||||||||||||||
| Revenue | $ | 766,409 | $ | 769,332 | $ | 721,443 | |||||||||||
| Cost of revenue (excluding amortization of intangible assets) | 429,840 | 440,511 | 441,411 | ||||||||||||||
| Selling, general and administrative | 142,101 | 132,803 | 146,311 | ||||||||||||||
| Amortization of intangible assets | 104,778 | 52,471 | 45,392 | ||||||||||||||
Intangible asset impairment | 108,974 | — | — | ||||||||||||||
| Goodwill impairment | 165,000 | 215,000 | — | ||||||||||||||
| Operating income (loss) | $ | (184,284) | $ | (71,453) | $ | 88,329 | |||||||||||
Unallocated Corporate (1) | |||||||||||||||||
| Selling, general and administrative | $ | 259,676 | $ | 258,121 | $ | 231,810 | |||||||||||
| Operating loss | $ | (259,676) | $ | (258,121) | $ | (231,810) | |||||||||||
(1) Operating loss for unallocated corporate consists of costs associated with departments such as senior executives, corporate accounting, legal, tax, human resources, treasury, and investor relations. | |||||||||||||||||
| Fiscal Year | |||||||||||||||||
| December 27, 2025 | December 28, 2024 | December 30, 2023 | |||||||||||||||
Revenue | |||||||||||||||||
RMS | $ | 846,082 | $ | 829,377 | $ | 792,343 | |||||||||||
DSA | 2,402,891 | 2,451,280 | 2,615,623 | ||||||||||||||
Manufacturing | 766,409 | 769,332 | 721,443 | ||||||||||||||
Total revenue | $ | 4,015,382 | $ | 4,049,989 | $ | 4,129,409 | |||||||||||
Operating Income (Loss) | |||||||||||||||||
RMS | $ | 44,567 | $ | 114,411 | $ | 154,666 | |||||||||||
DSA | 424,555 | 442,510 | 606,076 | ||||||||||||||
Manufacturing | (184,284) | (71,453) | 88,329 | ||||||||||||||
Segment operating income | 284,838 | 485,468 | 849,071 | ||||||||||||||
Unallocated corporate | (259,676) | (258,121) | (231,810) | ||||||||||||||
| Operating income | $ | 25,162 | $ | 227,347 | $ | 617,261 | |||||||||||
| Other income (expense): | |||||||||||||||||
| Interest income | 4,940 | 8,575 | 5,196 | ||||||||||||||
| Interest expense | (107,029) | (126,288) | (136,710) | ||||||||||||||
| Other income (expense), net | (22,576) | (16,520) | 95,537 | ||||||||||||||
Income (loss) before income taxes | $ | (99,503) | $ | 93,114 | $ | 581,284 | |||||||||||
| RMS | DSA | Manufacturing | Unallocated Corporate | Consolidated | |||||||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||||||||
| Capital Expenditures | |||||||||||||||||||||||||||||
| Fiscal Year | |||||||||||||||||||||||||||||
| 2025 | $ | 38,838 | $ | 132,959 | $ | 41,427 | $ | 5,928 | $ | 219,152 | |||||||||||||||||||
| 2024 | 64,134 | 128,356 | 38,500 | 1,977 | 232,967 | ||||||||||||||||||||||||
| 2023 | 52,819 | 204,891 | 58,134 | 2,684 | 318,528 | ||||||||||||||||||||||||
Depreciation and amortization (1) | |||||||||||||||||||||||||||||
| Fiscal Year | |||||||||||||||||||||||||||||
| 2025 | $ | 81,075 | $ | 174,030 | $ | 140,218 | $ | 7,989 | $ | 403,312 | |||||||||||||||||||
| 2024 | 73,812 | 191,126 | 89,964 | 6,839 | 361,741 | ||||||||||||||||||||||||
| 2023 | 55,570 | 174,719 | 79,982 | 3,853 | 314,124 | ||||||||||||||||||||||||
(1) Depreciation and amortization includes both inventory step up amortization expense and biological assets amortization expense. | |||||||||||||||||||||||||||||
| U.S. | Europe | Canada | Asia Pacific | Other (1) | Consolidated | ||||||||||||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||||||||||||||
| Fiscal Year | |||||||||||||||||||||||||||||||||||
| 2025 | $ | 2,141,773 | $ | 1,102,696 | $ | 501,025 | $ | 205,023 | $ | 64,865 | $ | 4,015,382 | |||||||||||||||||||||||
| 2024 | 2,239,977 | 1,078,146 | 482,093 | 196,952 | 52,821 | 4,049,989 | |||||||||||||||||||||||||||||
| 2023 | 2,347,486 | 1,076,937 | 487,305 | 200,833 | 16,848 | 4,129,409 | |||||||||||||||||||||||||||||
(1) The Other category represents operations located in Brazil, Israel, and Mauritius. | |||||||||||||||||||||||||||||||||||
| U.S. | Europe | Canada | Asia Pacific | Other (1) | Consolidated | ||||||||||||||||||||||||||||||
| (in thousands) | |||||||||||||||||||||||||||||||||||
| Fiscal Year | |||||||||||||||||||||||||||||||||||
| 2025 | $ | 919,236 | $ | 468,638 | $ | 163,337 | $ | 61,814 | $ | 42,194 | $ | 1,655,219 | |||||||||||||||||||||||
| 2024 | 941,621 | 412,967 | 147,039 | 66,046 | 36,341 | 1,604,014 | |||||||||||||||||||||||||||||
| 2023 | 964,176 | 407,375 | 157,483 | 74,605 | 36,102 | 1,639,741 | |||||||||||||||||||||||||||||
(1) The Other category represents operations located in Brazil and Mauritius. | |||||||||||||||||||||||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 18, 2026 | Showing above |
| 2024 | Feb 19, 2025 | |
| 2023 | Feb 14, 2024 | |
| 2022 | Feb 22, 2023 | |
| 2021 | Feb 16, 2022 | |
| 2020 | Feb 17, 2021 | |
| 2019 | Feb 11, 2020 | |
| 2018 | Feb 13, 2019 | |
| 2017 | Feb 13, 2018 | |
| 2016 | Feb 14, 2017 | |
| 2015 | Feb 12, 2016 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.